<DOC>
	<DOCNO>NCT01994668</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability pharmacokinetics 2-mg lorazepam intravenous administration healthy Japanese adult subject .</brief_summary>
	<brief_title>Phase 1 Study Characterize Safety Pharmacokinetics Single Intravenous Dose Lorazepam Healthy Japanese Adult Subjects</brief_title>
	<detailed_description />
	<mesh_term>Lorazepam</mesh_term>
	<criteria>Healthy Japanese male and/or female subject nonchildbearing potential . Body Mass Index 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg . History sensitivity lorazepam benzodiazepine . Evidence history acute narrowangle glaucoma sleep apnea syndrome . Significant psychiatric disorder , recurrent episode severe depression , subject serious suicidal risk .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>lorazepam</keyword>
	<keyword>intravenous</keyword>
	<keyword>pharmacolinetics</keyword>
	<keyword>healthy</keyword>
	<keyword>Japanese</keyword>
</DOC>